Avastin Alternatives Compared
Avastin | Rybrevant | Keytruda |
|
---|
Avastin (bevacizumab) | Rybrevant (amivantamab) | Keytruda (pembrolizumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Fallopian Tube Cancer, Cervical Cancer, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
Prescription only
Prescribed for Non-Small Cell Lung Cancer. Rybrevant may also be used for purposes not listed in this medication guide. |
Prescription only
Keytruda is a type of immunotherapy that helps boost the immune system's response against cancer. It may be used to treat many different types of cancer in adults and children and is given by... View more |
Related suggestions |
|||||||||||||||||||||||
More about Avastin (bevacizumab) | More about Rybrevant (amivantamab) | More about Keytruda (pembrolizumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Avastin has an average rating of 7.7 out of 10 from a total of 30 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 12% reported a negative effect. |
Rybrevant has an average rating of 9.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Keytruda has an average rating of 4.3 out of 10 from a total of 212 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 58% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Avastin side effects in more detail. |
See also: Rybrevant side effects in more detail. |
See also: Keytruda side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Avastin prices |
View all Rybrevant prices |
View all Keytruda prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other bevacizumab brands include: Alymsys, Avzivi, Mvasi, Vegzelma, Zirabev |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
480 hours |
271.2 hours |
624 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 45 drugs are known to interact with Avastin:
|
A total of 3 drugs are known to interact with Rybrevant:
|
A total of 16 drugs are known to interact with Keytruda:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
February 26, 2004 |
May 21, 2021 |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.